Bio-Techne Corporation is a global life sciences company providing tools and bioactive reagents for the research and clinical diagnostic communities. The Company's products assist scientific investigations into biological processes and the nature and progress of specific diseases. The Company, in partnership with Wilson Wolf, is creating products such as media and cytokines that are specifically tailored to G-Rex Bioreactors. Its segments include Protein Sciences and Diagnostics and Genomics. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, and tissue biopsy analysis.
Alto Dividendo
A empresa é uma grande pagadora de dividendos, com índice de distribuição mais recente de 68.69%.
Dividendo Estável
A empresa pagou dividendos regularmente nos últimos 5 anos, com índice de distribuição mais recente de 68.69%.
Sobreavaliada
O PE mais recente da empresa é 133.17, em uma faixa percentil alta de 3 anos.
Venda Institucional
As participações institucionais mais recentes são de 161.69M ações, uma redução de 4.59% em relação ao trimestre anterior.
Mantido por Wallace Weitz
O Super Investidor Wallace Weitz possui 802.15K ações desta empresa.